Pregnancy management tips

First, feed supply Many farmers believe that the mother quail should increase the amount of feed and supplementary foods to increase nutrition after pregnancy. However, many years of practical experience have proven that doing so would be counterproductive. The correct ratio of feed and auxiliary products should be that within 40 days after mating, the number of feedings should be once a day, and the feed amount of each should be generally not more than 35 grams of corn flour or full price feed and 20 grams of fish meal. The maximum amount of eggs is 5 eggs and 1 egg (75 grams). If you feed too much, it is very likely that your baby will be absorbed because of an excess of nutrients. Therefore, farmers who are not very experienced are not able to feed too much daily during this period.

After 40 days of pregnancy, the foetus has basically formed, and the feed and auxiliary products can gradually increase. Each two-day increment is 10 grams of flour and 3 grams of fish meal. By the end of the 50th day, the total amount must reach 75-80 grams of flour, 35 grams of fishmeal, and 1/2 egg per day per day (single feed at noon after cooking). After this, two times a day should be fed, once in the morning and once in the evening.

Second, drug feeding

In addition to the normal rotation of vitamin A, B, C, E and cod liver oil, after 50 days of pregnancy, vitamin C should be added to the feed every day (one dose of water), which can effectively prevent the occurrence of Achilles red claw disease. Regardless of the type of medicine you are feeding, spread it as evenly as possible into the food to avoid remaining.

Third, nursing care

When the mother-in-law is farrowing, the weather has not yet completely warmed up and the temperature difference between day and night is relatively large. Therefore, the nursing home should be kept warm. First, prepare a straw curtain made of straw. When it is about 1 month pregnant, first cover all the rear litters for the litter, so that the mother has a sufficient period of adaptation. In accordance with the expected date of production, the gates in the middle of the front and rear nests were opened 5 days in advance, so that the calves were familiar with the “birth-room” environment. At the same time, the front door was also covered with a straw curtain to prevent the mother-in-law from panic when the baby was released, which was detrimental to the birth. Before preparing for the above measures, the bottom of the “birth room” must be padded with rice straw or wheat straw for the purpose of heat preservation.

Zhang Jiusheng, Qicun Town, Jianggezhuang Town, Leting County, Tangshan City

After the mating is completed, the puerpera enters the gestation period. Feeding and nursing at this time are of vital importance throughout the breeding process. Therefore, attention must be paid to it. Otherwise, it may result in loss of cultivation and damage to breeding. Under normal circumstances, the majority of mother-in-law is in gestation during March, and farmers should grasp the following principles to ensure the success rate and birth rate.

Intermediates of Cladribine, Carvedilol, Lurasidone, olmesartan, Risedronate Sodium, Atazanavir, Saxagliptin, Dabigatran,Dapoxetine,Cefixime,Ceftaroline fosamil and etc.  

In the short span of time, we have emerged as most promising pharmaceutical intermediates manufacturers, chemical intermediates and bulk drug intermediates suppliers. Our consistent supply, quality products and dedication towards clients have opened up many international avenues for our growth.

In addition, the company also can follow the customer's product needs custom synthesis services

MAIN API  PRODUCTS   USP/BP

Major Pharmaceutical Intermediates

Items Descripation	Structure	Application
MICA ESTER CAS No: 246035-38-1 Purity: ≥98%		For Cefixime
EHATA CAS No: 64485-82-1 Purity: ≥98%		For Ceftazidine
2-Chloroadenine CAS No: 1839-18-5		For Cladribine, Fludarabine et al
Bicyclo(2,2,1)Heptane-2,3-di-exo-carboximide CAS No: 14805o-29-9		For Lurasidne
(R,R)-1,2-Bis(methanesulfonyloxy methyl)Cyclohexane CAS No: 186204-35-3		For Lurasidone
3-(Piperazin-1-yl)benzol[d] isothiazole CAS No: 87691-87-0		For Lurasidone
Trityl olmesartan CAS No: 144690-92-6 Purity: ≥98%		For olmesartan
3-Acetyl Pyridine CAS No: 350-03-8		For Risedronate Sodium
3-(AceticAcid)pyridine HCL CAS No: 6419-36-9		For Risedronate Sodium
Risedronic Acid CAS No: 105462-24-6		For Risedronate Sodium
3-Hydroxy-1-adamantyl-D-Glycine CAS No: 709031-29-8		For Saxagliptin
(1s,3s,5s)-3-(aminocarbonyl)-2-azabicyclo(3,1,0) hexane-2-carboxylic acid tert-butyl ester CAS No: 361440-67-7		For Saxagliptin
(S)-N-Boc-3- hydroxy-adamantylglycine CAS No: 361442-00-4		For Saxagliptin
2-Azabicyclo[3.1.0] hexane-3-carbonitrile, (1s,3s,5s)- CAS No: 866083-42-3		For Saxagliptin
Ethyl 3-(pyridin-2-ylamino) propanoate CAS No: 103041-38-9		For Dabigatran
N-(4-Cyanophenyl) glycine CAS No: 42288-26-6		For Dabigatran
4-methylamino-3-nitrobenzoic Acid CAS No: 41263-74-5		For Dabigatran
S-3-Amino-3-phenylpropanoic acid ethyl ester HCL CAS No: 167834-24-4		For Dapoxetine
(S)-3-Amino-3-Phemylpropan -1-ol CAS No: 82769-76-4		For Dapoxetine
(S)-3-Dimethylamino-3-Phemylpropanol CAS No: 82769-75-3		For Dapoxetine
4-{4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-butynil}-α,α-dimethyl benzene acetic acid CAS No: 832088-68-3		For Fexofenadine HCl
Methyl 2-(4-(4-chlorobutanoyl)phenyl)-2-methylpropanoate CAS No:154477-54-0		For Fexofenadine HCl
5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone CAS No 461432-22-4		For Dapagliflozin
4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether CAS No :461432-23-5		For Dapagliflozin

APIs & Intermediates

Mica Ester,Pharma Intermediates,Ciprofloxacin Hcl Uses,Active Pharmaceutical Ingredients

NINGBO VOICE BIOCHEMIC CO. LTD , https://www.pharma-voice.com